Furthermore, we intended to assess whether PNR could predict the prognosis of anti‐PD‐1‐containing therapy in patients with advanced solid tumor, such as gastric carcinoma, colon cancer, biliary tract carcinoma, or melanoma. Here, PDCD1 is linked to melanoma.